Open Access News

News from the open access movement


Tuesday, April 12, 2005

Defense of OA from Pfizer Inc.

Here are some of Ross Mayfield's notes on Janet Liggett's presentation at Buying and Selling eContent 2005. Liggett is with Pfizer Global Research & Development. 'Open Access is a revolution in pricing structure, institutional repositories provide new challenge in finding information, author archiving. It stands things on its head and encourages cost to be moved away from the reader, an important feature regardless of who pays for it eventually. Senior Scientist leaving Pfizer, but wanted to continue working in academia and asked if its possible to continue accessing their archive, but licensing makes it impossible, so a retiree that we want to keep working as a society is restricted from doing so. This is why Open Access matters.' (PS: Liggett's presentation is not itself online, at least so far.)